Advertisement

The Scientist

» pharmaceuticals and neuroscience

Most Recent

image: AstraZeneca Downsizing R&D Staff

AstraZeneca Downsizing R&D Staff

By | March 19, 2013

Positions for 1,600 scientists at the pharmaceutical company will be eliminated globally.

0 Comments

image: Fish Brain on Film

Fish Brain on Film

By | March 19, 2013

Improvements in light-sheet microscopy enable real-time activity imaging of almost every neuron in the brain of zebrafish larvae.

0 Comments

image: Mice Learn Faster with Human Glia

Mice Learn Faster with Human Glia

By | March 7, 2013

Mice with human brain cells showed enhanced synaptic plasticity and learning, suggesting glia may be key to our cognitive prowess.  

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Prion-like Proteins Cause Disease

Prion-like Proteins Cause Disease

By | March 3, 2013

Normal proteins with regions resembling disease-causing prions are responsible for an inherited disorder that affects the brain, muscle, and bone.

2 Comments

image: Sleep Protection

Sleep Protection

By | March 1, 2013

Inducing certain brain patterns extends non-REM sleep in mice.

0 Comments

image: Playing for Words

Playing for Words

By | February 28, 2013

Children with dyslexia have an easier time learning to read after playing action video games that don’t incorporate reading.

2 Comments

image: Tadpoles See with Extra Eyes

Tadpoles See with Extra Eyes

By | February 27, 2013

Blind tadpoles regain vision when new eyes are grafted onto their tails. 

0 Comments

image: Neurons Live Longer in New Brains

Neurons Live Longer in New Brains

By | February 25, 2013

Transplanting mouse neurons into rats allows the neurons to survive twice as long as they would in mice.

1 Comment

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
ORFLO
ORFLO

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
Advertisement
Molecular Devices
Molecular Devices
Life Technologies